一種新系統(tǒng)叫做腹腔鏡示波器控制器，允許進(jìn)行腹腔鏡手術(shù)的外科醫(yī)生在控制視頻示波器的時(shí)候，無需幫助就能夠維持雙手控制腹腔鏡設(shè)備。這套系統(tǒng)已經(jīng)獲得了美國食品藥品管理局的許可。

這套系統(tǒng)易于裝配，簡便易學(xué)，與標(biāo)準(zhǔn)套管針兼容。該產(chǎn)品是由GMP公司研制開發(fā)的，該公司一直致力于研制新型醫(yī)療保健設(shè)備。該公司目前正在評(píng)估對(duì)該系統(tǒng)進(jìn)行商業(yè)化操作的最佳途徑，包括授權(quán)、銷售和或者合作的機(jī)會(huì)。

GMP公司高級(jí)副總裁George Titus博士說：“FDA的許可相當(dāng)重要，是我們公司內(nèi)部研制開發(fā)項(xiàng)目的頂點(diǎn)。我們十分高興，這將能夠提升患者保健并有可能降低外科手術(shù)的成本。”

該公司研制的其他產(chǎn)品包括LifeSync無線心電圖系統(tǒng)、青光眼移植物以及Solight，這是一種外科設(shè)備照明系統(tǒng)。

Laparocision Scope Controller
 
A new system, called the laparocision scope controller, enables surgeons who are performing laparoscopic surgery to maintain two hands on the laparoscopic instruments while controlling the video scope without an assistant. The system has been cleared by the U.S. Food and Drug Administration (FDA).

The system is easy to set up and learn and is compatible with standard trocars. It was developed by GMP Companies, Inc. (Fort Lauderdale, FL, USA; www.gmpcompanies.com), which develops novel healthcare technologies. The company is currently assessing the best way to commercialize the system, including licensing, sale, and/or partnering opportunities.

“This important clearance is the culmination of our comprehensive in-house development program,” observed George Titus, Ph.D., senior vice president for GMP Companies. “We are very pleased that we will soon be able to offer healthcare professionals a new and exciting product that should enhance patient care and potentially lower the costs of surgeries.”

Other products developed by the company include the LifeSync wireless ECG system, a glaucoma implant, and Solight, a surgical instrument lighting system.